Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Gene_full_name.refGene	Function_description.refGene	Disease_description.refGene	Tissue_specificity(Uniprot).refGene	Expression(egenetics).refGene	Expression(GNF/Atlas).refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	cytoBand	cosmic70	ExAC_ALL	ExAC_AFR	ExAC_AMR	ExAC_EAS	ExAC_FIN	ExAC_NFE	ExAC_OTH	ExAC_SAS	gnomAD_genome_ALL	gnomAD_genome_AFR	gnomAD_genome_AMR	gnomAD_genome_ASJ	gnomAD_genome_EAS	gnomAD_genome_FIN	gnomAD_genome_NFE	gnomAD_genome_OTH	avsnp147	CLNALLELEID	CLNDN	CLNDISDB	CLNREVSTAT	CLNSIG	HGMD_pro_2019.1
chr	start	end	ref	alt																																													
1	2537672	2537672	C	A	intronic	MMEL1				8.87673673427084e-13	0.864055213068136	0.135944786930977	membrane metallo-endopeptidase-like 1	FUNCTION: Metalloprotease involved in sperm function, possibly by modulating the processes of fertilization and early embryonic development. Degrades a broad variety of small peptides with a preference for peptides shorter than 3 kDa containing neutral bulky aliphatic or aromatic amino acid residues. Shares the same substrate specificity with MME and cleaves peptides at the same amide bond (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Predominantly expressed in testis. Weakly expressed in brain, kidney and heart. {ECO:0000269|PubMed:11560781}.; 	unclassifiable (Anatomical System);cartilage;ovary;islets of Langerhans;developmental;colon;blood;uterus;breast;lung;bone;iris;testis;brain;mammary gland;stomach;	.	0.08338	0.20014	-0.657684922	16.09459778	200.55931	3.06168	1p36.32																								
1	11301714	11301714	A	G	exonic	MTOR		synonymous SNV	MTOR:NM_004958:exon10:c.T1437C:p.D479D	0.999999999999676	3.23627074202987e-13	2.27376199784302e-37	mechanistic target of rapamycin	FUNCTION: Serine/threonine protein kinase which is a central regulator of cellular metabolism, growth and survival in response to hormones, growth factors, nutrients, energy and stress signals. MTOR directly or indirectly regulates the phosphorylation of at least 800 proteins. Functions as part of 2 structurally and functionally distinct signaling complexes mTORC1 and mTORC2 (mTOR complex 1 and 2). Activated mTORC1 up-regulates protein synthesis by phosphorylating key regulators of mRNA translation and ribosome synthesis. This includes phosphorylation of EIF4EBP1 and release of its inhibition toward the elongation initiation factor 4E (eiF4E). Moreover, phosphorylates and activates RPS6KB1 and RPS6KB2 that promote protein synthesis by modulating the activity of their downstream targets including ribosomal protein S6, eukaryotic translation initiation factor EIF4B, and the inhibitor of translation initiation PDCD4. Stimulates the pyrimidine biosynthesis pathway, both by acute regulation through RPS6KB1- mediated phosphorylation of the biosynthetic enzyme CAD, and delayed regulation, through transcriptional enhancement of the pentose phosphate pathway which produces 5-phosphoribosyl-1- pyrophosphate (PRPP), an allosteric activator of CAD at a later step in synthesis, this function is dependent on the mTORC1 complex. Regulates ribosome synthesis by activating RNA polymerase III-dependent transcription through phosphorylation and inhibition of MAF1 an RNA polymerase III-repressor. In parallel to protein synthesis, also regulates lipid synthesis through SREBF1/SREBP1 and LPIN1. To maintain energy homeostasis mTORC1 may also regulate mitochondrial biogenesis through regulation of PPARGC1A. mTORC1 also negatively regulates autophagy through phosphorylation of ULK1. Under nutrient sufficiency, phosphorylates ULK1 at 'Ser- 758', disrupting the interaction with AMPK and preventing activation of ULK1. Also prevents autophagy through phosphorylation of the autophagy inhibitor DAP. mTORC1 exerts a feedback control on upstream growth factor signaling that includes phosphorylation and activation of GRB10 a INSR-dependent signaling suppressor. Among other potential targets mTORC1 may phosphorylate CLIP1 and regulate microtubules. As part of the mTORC2 complex MTOR may regulate other cellular processes including survival and organization of the cytoskeleton. Plays a critical role in the phosphorylation at 'Ser-473' of AKT1, a pro-survival effector of phosphoinositide 3-kinase, facilitating its activation by PDK1. mTORC2 may regulate the actin cytoskeleton, through phosphorylation of PRKCA, PXN and activation of the Rho-type guanine nucleotide exchange factors RHOA and RAC1A or RAC1B. mTORC2 also regulates the phosphorylation of SGK1 at 'Ser-422'. Regulates osteoclastogensis by adjusting the expression of CEBPB isoforms (By similarity). {ECO:0000250|UniProtKB:Q9JLN9, ECO:0000269|PubMed:12087098, ECO:0000269|PubMed:12150925, ECO:0000269|PubMed:12150926, ECO:0000269|PubMed:12231510, ECO:0000269|PubMed:12718876, ECO:0000269|PubMed:14651849, ECO:0000269|PubMed:15268862, ECO:0000269|PubMed:15467718, ECO:0000269|PubMed:15545625, ECO:0000269|PubMed:15718470, ECO:0000269|PubMed:18497260, ECO:0000269|PubMed:18762023, ECO:0000269|PubMed:18925875, ECO:0000269|PubMed:20516213, ECO:0000269|PubMed:20537536, ECO:0000269|PubMed:21659604, ECO:0000269|PubMed:23429703, ECO:0000269|PubMed:23429704}.; 	DISEASE: Smith-Kingsmore syndrome (SKS) [MIM:616638]: An autosomal dominant syndrome characterized by intellectual disability, macrocephaly, seizures, umbilical hernia, and facial dysmorphic features. {ECO:0000269|PubMed:25851998, ECO:0000269|PubMed:26542245}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in numerous tissues, with highest levels in testis. {ECO:0000269|PubMed:12408816, ECO:0000269|PubMed:7809080}.; 	ovary;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;endometrium;larynx;bone;thyroid;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;pharynx;blood;lens;skeletal muscle;breast;bile duct;pancreas;lung;epididymis;nasopharynx;placenta;macula lutea;visual apparatus;liver;cervix;spleen;head and neck;kidney;mammary gland;aorta;stomach;	occipital lobe;testis - interstitial;testis - seminiferous tubule;testis;skeletal muscle;parietal lobe;bone marrow;	0.97466	0.17086	-3.492013613	0.342061807	98.86161	2.15012	1p36.22		0.7170	0.2905	0.8029	0.8811	0.7454	0.7313	0.7577	0.7681	0.6129	0.2871	0.7751	0.6126	0.8837	0.7487	0.7263	0.7070	rs1135172	498006	not_specified	MedGen:CN169374	criteria_provided,_single_submitter	Benign	
1	54483911	54483911	C	A	upstream	LDLRAD1	dist=52			0.000101665235918743	0.577316980938709	0.422581353825373	low density lipoprotein receptor class A domain containing 1	.	.	.	.	.	0.11133	.	0.194852702	67.03231894	138.47283	2.56295	1p32.3																								
1	87573342	87573342	T	A	UTR3	HS2ST1	NM_012262:c.*2963T>A			0.535866622243903	0.463464750714515	0.000668627041582084	heparan sulfate 2-O-sulfotransferase 1	FUNCTION: Catalyzes the transfer of sulfate to the C2-position of selected hexuronic acid residues within the maturing heparan sulfate (HS). 2-O-sulfation within HS, particularly of iduronate residues, is essential for HS to participate in a variety of high- affinity ligand-binding interactions and signaling processes. Mediates 2-O-sulfation of both L-iduronyl and D-glucuronyl residues (By similarity). {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);lung;frontal lobe;cartilage;endometrium;islets of Langerhans;placenta;visual apparatus;hippocampus;testis;brain;skeletal muscle;stomach;	amygdala;superior cervical ganglion;prefrontal cortex;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.85379	0.14176	-0.005381972	53.50908233	45.88283	1.30316	1p22.3																		rs2972003						
1	109242237	109242237	C	A	exonic	PRPF38B		nonsynonymous SNV	PRPF38B:NM_001349762:exon6:c.C801A:p.H267Q,PRPF38B:NM_001349764:exon6:c.C690A:p.H230Q,PRPF38B:NM_001349765:exon6:c.C690A:p.H230Q,PRPF38B:NM_018061:exon6:c.C1236A:p.H412Q,PRPF38B:NM_001349757:exon7:c.C903A:p.H301Q,PRPF38B:NM_001349759:exon7:c.C684A:p.H228Q,PRPF38B:NM_001349761:exon7:c.C801A:p.H267Q,PRPF38B:NM_001349763:exon7:c.C690A:p.H230Q,PRPF38B:NM_001349766:exon7:c.C645A:p.H215Q,PRPF38B:NM_001349768:exon7:c.C645A:p.H215Q,PRPF38B:NM_001349771:exon7:c.C645A:p.H215Q,PRPF38B:NM_001349758:exon8:c.C684A:p.H228Q,PRPF38B:NM_001349767:exon8:c.C645A:p.H215Q,PRPF38B:NM_001349769:exon8:c.C645A:p.H215Q,PRPF38B:NM_001349770:exon8:c.C645A:p.H215Q	0.990908108110014	0.00909188800759528	3.8823906106752e-09	pre-mRNA processing factor 38B	FUNCTION: May be required for pre-mRNA splicing. {ECO:0000305}.; 	.	.	.	.	0.61332	0.10040	0.084621747	60.31493277	103.45472	2.19700	1p13.3																								
1	118499758	118499758	G	T	exonic	WDR3		stopgain	WDR3:NM_006784:exon25:c.G2521T:p.E841X	3.05076498982483e-07	0.999842601103122	0.000157093820379002	WD repeat domain 3	.	.	TISSUE SPECIFICITY: Ubiquitous.; 	unclassifiable (Anatomical System);medulla oblongata;lymph node;heart;sympathetic chain;adrenal cortex;colon;blood;skin;uterus;prostate;whole body;lung;endometrium;larynx;placenta;visual apparatus;testis;head and neck;germinal center;kidney;brain;mammary gland;aorta;stomach;	dorsal root ganglion;testis - interstitial;superior cervical ganglion;testis - seminiferous tubule;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.74985	0.11386	-0.194700582	39.24274593	1882.12176	7.97866	1p12																								
1	144901146	144901146	T	A	ncRNA_intronic	LOC100996724																			1q21.1										0.2972	0.1610	0.4117	0.3021	0.4918	0.3628	0.3283	0.3538	rs75259115						
1	146751782	146751782	A	T	exonic	CHD1L		synonymous SNV	CHD1L:NM_001256338:exon9:c.A1011T:p.I337I,CHD1L:NM_001256337:exon10:c.A780T:p.I260I,CHD1L:NM_001348454:exon10:c.A1167T:p.I389I,CHD1L:NM_001348456:exon10:c.A780T:p.I260I,CHD1L:NM_001348463:exon11:c.A780T:p.I260I,CHD1L:NM_001348466:exon11:c.A780T:p.I260I,CHD1L:NM_001348459:exon13:c.A780T:p.I260I,CHD1L:NM_001348461:exon13:c.A780T:p.I260I,CHD1L:NM_001348464:exon13:c.A780T:p.I260I,CHD1L:NM_001256336:exon14:c.A1323T:p.I441I,CHD1L:NM_001348453:exon14:c.A1284T:p.I428I,CHD1L:NM_001348455:exon14:c.A1134T:p.I378I,CHD1L:NM_001348457:exon14:c.A780T:p.I260I,CHD1L:NM_001348458:exon14:c.A780T:p.I260I,CHD1L:NM_001348460:exon14:c.A780T:p.I260I,CHD1L:NM_001348465:exon14:c.A780T:p.I260I,CHD1L:NM_001348452:exon15:c.A1407T:p.I469I,CHD1L:NM_001348462:exon15:c.A780T:p.I260I,CHD1L:NM_004284:exon15:c.A1623T:p.I541I,CHD1L:NM_024568:exon15:c.A1284T:p.I428I,CHD1L:NM_001348451:exon16:c.A1407T:p.I469I	1.05042366445767e-20	0.0151665061019938	0.984833493898006	chromodomain helicase DNA binding protein 1-like	FUNCTION: DNA helicase which plays a role in chromatin-remodeling following DNA damage. Targeted to sites of DNA damage through interaction with poly(ADP-ribose) and functions to regulate chromatin during DNA repair. Able to catalyze nucleosome sliding in an ATP-dependent manner. Helicase activity is strongly stimulated upon poly(ADP-ribose)-binding. {ECO:0000269|PubMed:18023026, ECO:0000269|PubMed:19661379}.; 	.	TISSUE SPECIFICITY: Frequently overexpressed in hepatomacellular carcinomas. {ECO:0000269|PubMed:18023026}.; 	lymphoreticular;medulla oblongata;smooth muscle;ovary;salivary gland;colon;fovea centralis;skin;uterus;prostate;whole body;cerebral cortex;endometrium;bone;thyroid;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;pharynx;blood;lens;skeletal muscle;breast;pancreas;lung;nasopharynx;trabecular meshwork;placenta;macula lutea;visual apparatus;hippocampus;liver;cervix;kidney;mammary gland;stomach;	superior cervical ganglion;testis - interstitial;testis;globus pallidus;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;	0.17016	0.12748	1.094934207	91.9143666	3413.85133	11.20476	1q21.1																								
1	243667938	243667938	T	A	UTR3	AKT3	NM_005465:c.*613A>T			0.99958539864029	0.000414600121510425	1.23819945657922e-09	v-akt murine thymoma viral oncogene homolog 3	FUNCTION: AKT3 is one of 3 closely related serine/threonine- protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT3 is the least studied AKT isoform. It plays an important role in brain development and is crucial for the viability of malignant glioma cells. AKT3 isoform may also be the key molecule in up-regulation and down-regulation of MMP13 via IL13. Required for the coordination of mitochondrial biogenesis with growth factor-induced increases in cellular energy demands. Down-regulation by RNA interference reduces the expression of the phosphorylated form of BAD, resulting in the induction of caspase- dependent apoptosis. {ECO:0000269|PubMed:18524868, ECO:0000269|PubMed:21191416}.; 	DISEASE: Note=AKT3 is a key modulator of several tumors like melanoma, glioma and ovarian cancer. Active AKT3 increases progressively during melanoma tumor progression with highest levels present in advanced-stage metastatic melanomas. Promotes melanoma tumorigenesis by decreasing apoptosis. Plays a key role in the genesis of ovarian cancers through modulation of G2/M phase transition. With AKT2, plays a pivotal role in the biology of glioblastoma.; DISEASE: Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 (MPPH2) [MIM:615937]: A syndrome characterized by megalencephaly, hydrocephalus, and polymicrogyria; polydactyly may also be seen. There is considerable phenotypic similarity between this disorder and the megalencephaly-capillary malformation syndrome. {ECO:0000269|PubMed:22500628, ECO:0000269|PubMed:22729223, ECO:0000269|PubMed:22729224}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: In adult tissues, it is highly expressed in brain, lung and kidney, but weakly in heart, testis and liver. In fetal tissues, it is highly expressed in heart, liver and brain and not at all in kidney.; 	ovary;colon;parathyroid;skin;retina;uterus;prostate;optic nerve;whole body;frontal lobe;cochlea;bone;testis;germinal center;spinal ganglion;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;hypothalamus;lens;skeletal muscle;breast;lung;adrenal gland;placenta;hippocampus;visual apparatus;liver;spleen;kidney;mammary gland;stomach;	amygdala;dorsal root ganglion;occipital lobe;superior cervical ganglion;medulla oblongata;pons;atrioventricular node;subthalamic nucleus;fetal brain;prefrontal cortex;globus pallidus;appendix;ciliary ganglion;trigeminal ganglion;parietal lobe;cingulate cortex;	0.51738	0.24974	-0.251530012	35.42108988	6.85051	0.25446	1q43										0.0001	0.0002	0	0	0	0	7.089e-05	0							
